Table 1.
Patient demographics and medical information
| Patient | Sex | Age | Weight (kg) | Co- infection |
Symptom | Started with vaccination program* | Suppl. oxygen | Medication$ | Antibiotics | Other§ |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | M | 2 months¥ | 4.7 | – | Dyspnea | No | Yes |
Ipratropium (0.25 mg) Salbutamol (2.5 mg) Xylometazoline (0.25 mg/ml) Paracetamol (60 mg) |
No | No |
| 2 | F | 1 month | 5.0 | – | Bronchiolitis | No | Yes |
Xylometazoline (0.25 mg/ml) Paracetamol (60 mg) |
No | Vitamin K oil droplets |
| 3 | M | 10 days | 3.8 | – | Sinusitis | No | Yes |
Xylometazoline (0.25 mg/ml) Paracetamol (60 mg) |
Amoxicillin (500 mg/ml) Cefotaxime (500 mg/ml) |
No |
| 4 | M | 2 months | 6.4 | RV | Dyspnea | No | Yes |
Xylometazoline (0.25 mg/ml) Paracetamol (120 mg) |
No |
Vitamin K oil droplets Cholecalciferol (10 µg) |
| 5 | M | 7 months | 11.1 | RV | Bronchiolitis & Tachypnea | Yes | Yes |
Xylometazoline (0.25 mg/ml) Paracetamol (240 mg) Hypertonic saline inhalation (2.5 mg/ml) |
No |
Cholecalciferol (10 µg) |
| 6 | F | 3 months | 6.0 | – | Bronchiolitis & Dyspnea | Yes | Yes |
Ibuprofen (20 mg/ml) Paracetamol (120 mg) Hypertonic saline inhalation (0.9 mg/ml) |
No |
Cholecalciferol (10 µg) |
Standard medical treatment was only supportive and aimed at relieving symptoms. (¥) born premature, (*) according to Dutch vaccination program, ($) was given if needed, (§) was given once a day